Involvement of hydrogen sulfide in the progression of renal fibrosis

Abstract. Objective. Renal fibrosis is the most common manifestation of chronic kidney disease (CKD). Noting that existing treatments of renal fibrosis only slow disease progression but do not cure it, there is an urgent need to identify novel therapies. Hydrogen sulfide (H2S) is a newly discovered...

Full description

Bibliographic Details
Main Authors: Yu Wang, Qi-Qi Xing, Jing-Ke Tu, Wen-Bin Tang, Xiang-Ning Yuan, Yan-Yun Xie, Wei Wang, Zhang-Zhe Peng, Ling Huang, Hui Xu, Jiao Qin, Xiang-Cheng Xiao, Li-Jian Tao, Qiong-Jing Yuan, Xin Chen and Li-Min Chen
Format: Article
Language:English
Published: Wolters Kluwer 2019-12-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000000537
_version_ 1818821775162605568
author Yu Wang
Qi-Qi Xing
Jing-Ke Tu
Wen-Bin Tang
Xiang-Ning Yuan
Yan-Yun Xie
Wei Wang
Zhang-Zhe Peng
Ling Huang
Hui Xu
Jiao Qin
Xiang-Cheng Xiao
Li-Jian Tao
Qiong-Jing Yuan
Xin Chen and Li-Min Chen
author_facet Yu Wang
Qi-Qi Xing
Jing-Ke Tu
Wen-Bin Tang
Xiang-Ning Yuan
Yan-Yun Xie
Wei Wang
Zhang-Zhe Peng
Ling Huang
Hui Xu
Jiao Qin
Xiang-Cheng Xiao
Li-Jian Tao
Qiong-Jing Yuan
Xin Chen and Li-Min Chen
author_sort Yu Wang
collection DOAJ
description Abstract. Objective. Renal fibrosis is the most common manifestation of chronic kidney disease (CKD). Noting that existing treatments of renal fibrosis only slow disease progression but do not cure it, there is an urgent need to identify novel therapies. Hydrogen sulfide (H2S) is a newly discovered endogenous small gas signaling molecule exerting a wide range of biologic actions in our body. This review illustrates recent experimental findings on the mechanisms underlying the therapeutic effects of H2S against renal fibrosis and highlights its potential in future clinical application. Data sources. Literature was collected from PubMed until February 2019, using the search terms including “Hydrogen sulfide,” “Chronic kidney disease,” “Renal interstitial fibrosis,” “Kidney disease,” “Inflammation factor,” “Oxidative stress,” “Epithelial-to-mesenchymal transition,” “H2S donor,” “Hypertensive kidney dysfunction,” “Myofibroblasts,” “Vascular remodeling,” “transforming growth factor (TGF)-beta/Smads signaling,” and “Sulfate potassium channels.” Study selection. Literature was mainly derived from English articles or articles that could be obtained with English abstracts. Article type was not limited. References were also identified from the bibliographies of identified articles and the authors’ files. Results. The experimental data confirmed that H2S is widely involved in various renal pathologies by suppressing inflammation and oxidative stress, inhibiting the activation of fibrosis-related cells and their cytokine expression, ameliorating vascular remodeling and high blood pressure, stimulating tubular cell regeneration, as well as reducing apoptosis, autophagy, and hypertrophy. Therefore, H2S represents an alternative or additional therapeutic approach for renal fibrosis. Conclusions. We postulate that H2S may delay the occurrence and progress of renal fibrosis, thus protecting renal function. Further experiments are required to explore the precise role of H2S in renal fibrosis and its application in clinical treatment.
first_indexed 2024-12-18T23:13:33Z
format Article
id doaj.art-afd2f6e680904671969b878bf85febdb
institution Directory Open Access Journal
issn 0366-6999
2542-5641
language English
last_indexed 2024-12-18T23:13:33Z
publishDate 2019-12-01
publisher Wolters Kluwer
record_format Article
series Chinese Medical Journal
spelling doaj.art-afd2f6e680904671969b878bf85febdb2022-12-21T20:48:17ZengWolters KluwerChinese Medical Journal0366-69992542-56412019-12-01132232872288010.1097/CM9.0000000000000537201912050-00015Involvement of hydrogen sulfide in the progression of renal fibrosisYu WangQi-Qi XingJing-Ke TuWen-Bin TangXiang-Ning YuanYan-Yun XieWei WangZhang-Zhe PengLing HuangHui XuJiao QinXiang-Cheng XiaoLi-Jian TaoQiong-Jing YuanXin Chen and Li-Min ChenAbstract. Objective. Renal fibrosis is the most common manifestation of chronic kidney disease (CKD). Noting that existing treatments of renal fibrosis only slow disease progression but do not cure it, there is an urgent need to identify novel therapies. Hydrogen sulfide (H2S) is a newly discovered endogenous small gas signaling molecule exerting a wide range of biologic actions in our body. This review illustrates recent experimental findings on the mechanisms underlying the therapeutic effects of H2S against renal fibrosis and highlights its potential in future clinical application. Data sources. Literature was collected from PubMed until February 2019, using the search terms including “Hydrogen sulfide,” “Chronic kidney disease,” “Renal interstitial fibrosis,” “Kidney disease,” “Inflammation factor,” “Oxidative stress,” “Epithelial-to-mesenchymal transition,” “H2S donor,” “Hypertensive kidney dysfunction,” “Myofibroblasts,” “Vascular remodeling,” “transforming growth factor (TGF)-beta/Smads signaling,” and “Sulfate potassium channels.” Study selection. Literature was mainly derived from English articles or articles that could be obtained with English abstracts. Article type was not limited. References were also identified from the bibliographies of identified articles and the authors’ files. Results. The experimental data confirmed that H2S is widely involved in various renal pathologies by suppressing inflammation and oxidative stress, inhibiting the activation of fibrosis-related cells and their cytokine expression, ameliorating vascular remodeling and high blood pressure, stimulating tubular cell regeneration, as well as reducing apoptosis, autophagy, and hypertrophy. Therefore, H2S represents an alternative or additional therapeutic approach for renal fibrosis. Conclusions. We postulate that H2S may delay the occurrence and progress of renal fibrosis, thus protecting renal function. Further experiments are required to explore the precise role of H2S in renal fibrosis and its application in clinical treatment.http://journals.lww.com/10.1097/CM9.0000000000000537
spellingShingle Yu Wang
Qi-Qi Xing
Jing-Ke Tu
Wen-Bin Tang
Xiang-Ning Yuan
Yan-Yun Xie
Wei Wang
Zhang-Zhe Peng
Ling Huang
Hui Xu
Jiao Qin
Xiang-Cheng Xiao
Li-Jian Tao
Qiong-Jing Yuan
Xin Chen and Li-Min Chen
Involvement of hydrogen sulfide in the progression of renal fibrosis
Chinese Medical Journal
title Involvement of hydrogen sulfide in the progression of renal fibrosis
title_full Involvement of hydrogen sulfide in the progression of renal fibrosis
title_fullStr Involvement of hydrogen sulfide in the progression of renal fibrosis
title_full_unstemmed Involvement of hydrogen sulfide in the progression of renal fibrosis
title_short Involvement of hydrogen sulfide in the progression of renal fibrosis
title_sort involvement of hydrogen sulfide in the progression of renal fibrosis
url http://journals.lww.com/10.1097/CM9.0000000000000537
work_keys_str_mv AT yuwang involvementofhydrogensulfideintheprogressionofrenalfibrosis
AT qiqixing involvementofhydrogensulfideintheprogressionofrenalfibrosis
AT jingketu involvementofhydrogensulfideintheprogressionofrenalfibrosis
AT wenbintang involvementofhydrogensulfideintheprogressionofrenalfibrosis
AT xiangningyuan involvementofhydrogensulfideintheprogressionofrenalfibrosis
AT yanyunxie involvementofhydrogensulfideintheprogressionofrenalfibrosis
AT weiwang involvementofhydrogensulfideintheprogressionofrenalfibrosis
AT zhangzhepeng involvementofhydrogensulfideintheprogressionofrenalfibrosis
AT linghuang involvementofhydrogensulfideintheprogressionofrenalfibrosis
AT huixu involvementofhydrogensulfideintheprogressionofrenalfibrosis
AT jiaoqin involvementofhydrogensulfideintheprogressionofrenalfibrosis
AT xiangchengxiao involvementofhydrogensulfideintheprogressionofrenalfibrosis
AT lijiantao involvementofhydrogensulfideintheprogressionofrenalfibrosis
AT qiongjingyuan involvementofhydrogensulfideintheprogressionofrenalfibrosis
AT xinchenandliminchen involvementofhydrogensulfideintheprogressionofrenalfibrosis